![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 25, 2021 8:17:43 PM
Yes an eau & approval by the FDA is very important. For the U.S.,Europe, & other countries will not order/buy an unapproved drug. Zyesami can also treat other inflammatory lung diseases. So drug approval is required to treat other diseases. Also Relief therapeutics wants to uplist to the Nasdaq. So again the company needs an approved drug/product. No investor will buy shares on the Nasdaq with an unapproved drug. I'm hoping that the FDA is reviewing the recent clinical trials data. I'm very long on Relief therapeutics stock.......
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM